Comprehensive coverage and timeline for Next. Aggregated from 4 sources with 4 articles.
How Next coverage has developed over time.
Topics frequently covered alongside Next.
Microsoft is incorporating rack-scale NVIDIA Rubin systems into its 'Fairwater' AI superfactories to power advanced model training starting late 2026. This follows NVIDIA's Rubin unveiling, promising leaps in compute efficiency for cloud-scale AI. The move bolsters US AI infrastructure amid enterprise agent adoption rates surging in datacenters.
devflokers.comNvidia announced on March 13, 2026, major investments in capital and its latest chips to develop the next layer of AI cloud infrastructure, targeting US data centers. The initiative involves partnerships with hyperscalers to deploy Blackwell GPUs at scale. This positions Nvidia to dominate AI compute markets valued at over $100 billion annually. Experts note it accelerates US leadership in AI amid global competition.
wsj.comApple TV+ announced *Shrinking* Season 3 premieres next week, rated TV-MA with an A from critics for its humor on family dynamics and healing. The series explores loss and forgiveness, building a 'found family vibe' as noted by cast insights. Seasons 1-2 are available now for catch-up viewing. The release adds to streaming momentum during Oscars weekend.
dailyflashshow.com
Image: STAT NewsAn FDA advisory committee has recommended the development of next year's flu vaccine, as new data from the CDC indicates the current 2025-2026 flu vaccine provides moderate protection against hospitalization for vaccinated individuals despite concerns about late-emerging H3N2 strains. The committee reviewed winter flu shot effectiveness reports published in the CDC's online MMWR journal, which showed moderate protective efficacy against severe outcomes requiring hospitalization. The timing of vaccine selection remains critical as late-emerging H3N2 variants can significantly undermine vaccine effectiveness, a concern flagged by the committee during this year's review. Current guidance continues to emphasize vaccination for those at high risk of severe illness, particularly elderly and immunocompromised populations.
statnews.com